PharmaBoardroom

Since gaining independence in 1965, Singapore has invested heavily in moving beyond being a mere supplier of low cost labor like many of its Asian…

Merck Czech Republic’s MD reveals his plan to double Merck operations within the next five years and talks about the impact of the recent…

Rafael Suarez, general manager of Ferring in Mexico, explains how the Swiss biopharmaceutical company is adapting to the recent dynamics affecting…

As President of Biopharma Activities for Merck in France, Pierre-Henry Longeray reveals how France is the third ranked affiliate after the US and…

Mohammad Afshar, CEO of Ariana Pharma, shares his insights on the importance of decision support tools, big data’s impact on the healthcare…

The following chart illustrates the various bottlenecks restraining the development of France's pharmaceutical industry, including lack of…

The Managing Director of HUMAN BioPlazma, Ákos Tóth, highlights the transformational growth that the business has experienced since becoming a part…

Michaela Hrdlickova of Biogen elaborates on how it is the industry’s responsibility to educate all stakeholders within the Czech Republic in order…

Providing universal health coverage to the nation’s roughly 10 million citizens, Hungary’s National Health Insurance Fund (OEP) has one of the…

Biotest France’s Olivier Samama discusses their recent re-entry into France, their focus on homecare treatment, and their expertise in fractionation…

The GM of France for Bristol-Myers Squibb (BMS) discusses becoming a “diversified biopharma company”, their commitment to remaining a model of…

Roland Berger’s Patrick Biecheler discusses the French healthcare system, their role in offering specialized consultancy services to the…